94 related articles for article (PubMed ID: 23458184)
1. Nucleolar molecular signature of pluripotent stem cells.
Pliss A; Kuzmin AN; Kachynski AV; Jiang H; Hu Z; Ren Y; Feng J; Prasad PN
Anal Chem; 2013 Apr; 85(7):3545-52. PubMed ID: 23458184
[TBL] [Abstract][Full Text] [Related]
2. Cell-free extract from porcine induced pluripotent stem cells can affect porcine somatic cell nuclear reprogramming.
No JG; Choi MK; Kwon DJ; Yoo JG; Yang BC; Park JK; Kim DH
J Reprod Dev; 2015; 61(2):90-8. PubMed ID: 25736622
[TBL] [Abstract][Full Text] [Related]
3. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
[TBL] [Abstract][Full Text] [Related]
4. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors.
Löhle M; Hermann A; Glass H; Kempe A; Schwarz SC; Kim JB; Poulet C; Ravens U; Schwarz J; Schöler HR; Storch A
Stem Cells; 2012 Mar; 30(3):570-9. PubMed ID: 22213586
[TBL] [Abstract][Full Text] [Related]
5. Analysis of differential proteomes of induced pluripotent stem cells by protein-based reprogramming of fibroblasts.
Jin J; Kwon YW; Paek JS; Cho HJ; Yu J; Lee JY; Chu IS; Park IH; Park YB; Kim HS; Kim Y
J Proteome Res; 2011 Mar; 10(3):977-89. PubMed ID: 21175196
[TBL] [Abstract][Full Text] [Related]
6. Profiling stem cells using quantitative PCR protein assays.
Ruff D; Lieu PT
Methods Mol Biol; 2013; 997():225-36. PubMed ID: 23546760
[TBL] [Abstract][Full Text] [Related]
7. Quantitative proteomic analysis of mouse embryonic fibroblasts and induced pluripotent stem cells using 16O/18O labeling.
Huang X; Tian C; Liu M; Wang Y; Tolmachev AV; Sharma S; Yu F; Fu K; Zheng J; Ding SJ
J Proteome Res; 2012 Apr; 11(4):2091-102. PubMed ID: 22375802
[TBL] [Abstract][Full Text] [Related]
8. Using microRNAs to enhance the generation of induced pluripotent stem cells.
Li Z; Rana TM
Curr Protoc Stem Cell Biol; 2012; Chapter 4():Unit 4A.4. PubMed ID: 22415842
[TBL] [Abstract][Full Text] [Related]
9. Generation of induced pluripotent stem cell lines from human fibroblasts via retroviral gene transfer.
Miller JD; Schlaeger TM
Methods Mol Biol; 2011; 767():55-65. PubMed ID: 21822867
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming somatic cells into pluripotent stem cells using miRNAs.
Anokye-Danso F
Methods Mol Biol; 2014; 1150():273-81. PubMed ID: 24744006
[TBL] [Abstract][Full Text] [Related]
11. Comparison of reprogramming efficiency between transduction of reprogramming factors, cell-cell fusion, and cytoplast fusion.
Hasegawa K; Zhang P; Wei Z; Pomeroy JE; Lu W; Pera MF
Stem Cells; 2010 Aug; 28(8):1338-48. PubMed ID: 20572011
[TBL] [Abstract][Full Text] [Related]
12. Comparative study using Raman microspectroscopy reveals spectral signatures of human induced pluripotent cells more closely resemble those from human embryonic stem cells than those from differentiated cells.
Tan Y; Konorov SO; Schulze HG; Piret JM; Blades MW; Turner RF
Analyst; 2012 Oct; 137(19):4509-15. PubMed ID: 22888493
[TBL] [Abstract][Full Text] [Related]
13. Modeling neuronal defects associated with a lysosomal disorder using patient-derived induced pluripotent stem cells.
Lemonnier T; Blanchard S; Toli D; Roy E; Bigou S; Froissart R; Rouvet I; Vitry S; Heard JM; Bohl D
Hum Mol Genet; 2011 Sep; 20(18):3653-66. PubMed ID: 21685203
[TBL] [Abstract][Full Text] [Related]
14. Changes in biomolecular profile in a single nucleolus during cell fixation.
Kuzmin AN; Pliss A; Prasad PN
Anal Chem; 2014 Nov; 86(21):10909-16. PubMed ID: 25268694
[TBL] [Abstract][Full Text] [Related]
15. Elevated coding mutation rate during the reprogramming of human somatic cells into induced pluripotent stem cells.
Ji J; Ng SH; Sharma V; Neculai D; Hussein S; Sam M; Trinh Q; Church GM; McPherson JD; Nagy A; Batada NN
Stem Cells; 2012 Mar; 30(3):435-40. PubMed ID: 22162363
[TBL] [Abstract][Full Text] [Related]
16. From skin to the treatment of diseases--the possibilities of iPS cell research in dermatology.
Galach M; Utikal J
Exp Dermatol; 2011 Jun; 20(6):523-8. PubMed ID: 21585557
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic mutation of ALK2 inhibits induced pluripotent stem cell reprogramming and maintenance: mechanisms of reprogramming and strategy for drug identification.
Hamasaki M; Hashizume Y; Yamada Y; Katayama T; Hohjoh H; Fusaki N; Nakashima Y; Furuya H; Haga N; Takami Y; Era T
Stem Cells; 2012 Nov; 30(11):2437-49. PubMed ID: 22949078
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins.
Rowland TJ; Blaschke AJ; Buchholz DE; Hikita ST; Johnson LV; Clegg DO
J Tissue Eng Regen Med; 2013 Aug; 7(8):642-53. PubMed ID: 22514096
[TBL] [Abstract][Full Text] [Related]
19. Reprogramming of the MHC-I and its regulation by NFκB in human-induced pluripotent stem cells.
Pick M; Ronen D; Yanuka O; Benvenisty N
Stem Cells; 2012 Dec; 30(12):2700-8. PubMed ID: 22987393
[TBL] [Abstract][Full Text] [Related]
20. Reprogramming human dermal fibroblast into induced pluripotent stem cells using nonintegrative Sendai virus for transduction.
Tai L; Teoh HK; Cheong SK
Malays J Pathol; 2018 Dec; 40(3):325-329. PubMed ID: 30580364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
